Studies have found abnormal expression of SNHG4 in many diseases, for example, decreased expression in diabetic retinopathy and acute myeloid leukemia [7, 8], while increased expression in endometriosis, gastric cancer, neuroblastoma and lung cancer [9–12]. Here, SNHG4 is linked to lung carcinoma.